Threshold Pharmaceuticals (THLD)

Add to Watchlists
Create an Alert
3.83 -0.19  -4.73% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
THLD Price Chart
View All Events

THLD Events

Date Type Description
Mar 06 Earnings Threshold Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.11.
Dec 10 Misc Threshold Pharmaceuticals Announces Presentation and Webcast at the Oppenheimer 24th Annual Healthcare Conference
Nov 04 Earnings Threshold Pharmaceuticals Reports Third Quarter 2013 Financial and Operational Results. Estimate: -0.10.
Aug 01 Earnings Threshold Pharmaceuticals Reports Second Quarter 2013 Financial and Operational Results. Estimate: -0.09.
May 02 Earnings Threshold Pharmaceuticals Reports First Quarter 2013 Financial and Operational Results. Estimate: -0.08.
View All Performance Charts

THLD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Threshold Pharmaceuticals is down 16.19% over the last year vs S&P 500 Total Return up 23.54%, Eli Lilly and up 9.08%, and Biogen Idec up 42.37%.

Get Quote for

Portfolio Strategies Featuring THLD

Did Threshold Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

THLD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Threshold Pharmaceuticals, Inc. is a biotechnology company. It focuses on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
THLD 3.83 -0.19 -4.73% 227.29M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.